Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-01 4:15 pm Purchase | 2023-11-24 | 13G | Spyre Therapeutics, Inc. SYRE | Commodore Capital LP | 1,834,084 6.100% | 1,834,084 (New Position) | Filing History |
| 2023-11-29 5:08 pm Purchase | 2023-11-24 | 13D | Spyre Therapeutics, Inc. SYRE | Fairmount Funds Management LLC | 3,813,901 12.700% | 3,813,901 (New Position) | Filing History |
| 2023-11-14 3:13 pm Purchase | 2023-09-08 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deutsch Peter E. | 383,659 9.480% | 383,659 (New Position) | Filing History |
| 2023-07-28 09:01 am Purchase | 2023-07-19 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Polar Capital Holdings Plc | 157,448 5.020% | 157,448 (New Position) | Filing History |
| 2023-07-18 4:01 pm Purchase | 2023-07-06 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Logos Global Management LP | 254,000 8.100% | 254,000 (New Position) | Filing History |
| 2023-07-10 4:16 pm Purchase | 2023-06-28 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Venrock Healthcare Capital Partners III, L.P. | 319,200 9.990% | 319,200 (New Position) | Filing History |
| 2023-07-03 4:20 pm Purchase | 2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Affinity Healthcare Fund, LP | 299,080 9.230% | 299,080 (New Position) | Filing History |
| 2023-06-30 5:24 pm Purchase | 2023-06-22 | 13D | Aeglea BioTherapeutics, Inc. AGLE | Fairmount Funds Management LLC | 783,600 19.990% | 783,600 (New Position) | Filing History |
| 2023-06-30 4:20 pm Purchase | 2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE | EcoR1 Capital Fund Qualified L.P. | 200,000 6.400% | 200,000 (New Position) | Filing History |
| 2023-06-30 4:00 pm Purchase | 2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Biotechnology Master Fund, Ltd. | 290,322 9.990% | 290,322 (New Position) | Filing History |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Nantahala Capital Management, LLC | 184,452 7.500% | 71,910 (+63.90%) | Filing History |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | ORBIMED ADVISORS LLC | 71,889 2.900% | -86,356 (-54.57%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | BAKER BROS. ADVISORS LP | 255,361 9.900% | 53,581 (+26.55%) | Filing History |
| 2023-02-14 2:51 pm Purchase | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Rock Springs Capital Management LP | 136,556 5.550% | 136,556 (New Position) | Filing History |
| 2023-02-14 06:04 am Purchase | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | BCLS II Equity Opportunities LP | 213,908 8.700% | 100,000 (+87.79%) | Filing History |
| 2023-02-13 08:41 am Purchase | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Suvretta Capital Management, LLC | 255,055 9.990% | 152,215 (+148.01%) | Filing History |
| 2023-02-03 11:43 am Sale | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | PICTET ASSET MANAGEMENT SA | 0 0.000% | -100,773 (Position Closed) | Filing History |
| 2023-01-10 4:36 pm Sale | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Integrated Core Strategies (US) LLC | 125,259 5.100% | -6,372 (-4.84%) | Filing History |
| 2022-12-01 4:07 pm Purchase | 2022-11-23 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Integrated Core Strategies (US) LLC | 131,631 5.300% | 131,631 (New Position) | Filing History |
| 2022-06-09 3:20 pm Sale | 2022-05-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | BlackRock Inc. BLK | 117,707 4.800% | -2,233 (-1.86%) | Filing History |